NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute)
New York, New York 10016
2 studies enrolling now · 3 studies all time
What they study most
Acquired Resistance to KRAS G12C Inhibitor, Advanced Solid Tumor, BRAF, BRAF Gene Mutation, BRAF Mutation-Related Tumors, BRAF V600 Mutation, BRAF V600E, Bladder Cancer, Brain Metastases, Cervical Cancer, Colorectal Cancer, Colorectal Carcinoma